1VAKIL N,VAN ZATEN SV,KAHRILAS P,et al.The Montreal definition and classification of gastroesophagel reflux disease:A Globa evidence-based consensus[J].Am J Gastroenterol,2006,101:1.
3IKUO H,JOEL E R.ACG practice guidelines:esophageal reflux testing.Am J Gastroenterol,2007,102:668.
4O'CONNOR JF,SINGER ME,RICHTER JE.The costeffectiveness of strategies to assess gastroesophageal reflux as an exacerbating factor in asthma[J].Am J Gastroenterol,1999,94:1472.
5Gob K L.Changing epidlemiology of gastroeso phageal reflux disease in the Asian-Pacific region:an overview[J].J Gastroenterol Hepatol,2004,19(Supple)3:S22.
6Calabmse C,Fabbri A,Bortolotti M,et al.Dilated intercellular spacesa as a marker of oesophageal damage;comparative results in gastro-oesophageal reflux disease with or without bile reflux[J].Aliment Pharmacol Ther,2003,18:525-532.
7KAHRILAS PJ,QUlGLEY EM.Clinical esophageal pH recording:Atechnical reviewfor practice guideline development[J].Gastroenterology,1996,110:1982.
8PANDOLFINO JE,SCHREINER MA,LEE TJ,et al.Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure[J].Am J Gastroenteml,2005.100:1466.
9SHAY SS,BOMELI S,RICHTER J.Muhichannel intraluminal impedance accurately detects fasting.recumbent reflux events and their clearing[J].Am J Physiol Gastrointest Liver Physiol,2002,283:G376.
10VELA MF,Camacho-Lobato L,Srinivasan R,et al.SimultaIIeous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux:Effect of omeprazole[J].Gastroenterology.2001,120:1599.
3OZUCELIK D N.KARACA M A.SIVRI B. Effectivenessof pre-emptive metoclopramide infusion in alleviating pain,discomfort and nausea associated with nasogastric tube in-sertion :a randomized, double-blind, placebo-controlled trial[J]. Int J Clin Pract,2005,59:1422 -1427.
4LEVEIN N G,THORN S E'WATTWIL M. Effects ofclonidine and dopamine on gastric tone[J]. Eur J An-aesthesiol, 2002,19 :99 -104.
5梁鹏.促胃肠动力药物探析[J].医药前沿,2011,20(1):18-19.
6BASSIL A K,DASS N B,MURRAY C D,et al. Proki-neticin-2 , motilin,ghrelin and metoclopramide: proki-netic utility in mouse stomach and colon [ J]. Eur JPharmacol, 2005,524(1 - 3) : 328 - 332.
7AMARAPURKAR D N'RANE P. Randomised, doub-le-blind ,comparative study to evaluate the efficacy andsafety of ganaton(itopridehydrochloride)and mosapridecitrate in the management of functional dyspepsiaQJ. JIndian Med Assoc,2004,102:735 - 737,760.
8FAGENHOLZ P J,FERNANDEZ-DEL C C, HARRISN S,et al. Direct medical costs of acute pancreatitishospitalizations in the United States [J]. Pancreas,2007,35:302-307.
9LIN Z. MADRAS B K. Human genetics and pharma-cology of neurotransmitter transporters[J]. Handb ExpPharmacol,2006 ,175:327 -376.
10SRIRAJASKANHTAN R, WATKINS J, MARELLIL,et al. Expression of somatostatin and dopamine 2 re-ceptors in neuroendocrine tumours and the potentialrole for new biotherapies [ J ]. Neuroendocrinology,2009,89:308-314.
